NORTION Obtains Import Medical Device Registration Certificate in Indonesia

Shanghai Nortion Medical Achieves Significant Breakthrough in Indonesia: Composite Steep Pulse Therapy Device and Disposable Ablation Electrode Needles Secure Import Medical Device Distribution License.

Recently, Shanghai Nortion Medical Technology Co., Ltd. achieved a major milestone in Indonesia for its independently developed and manufactured Composite Steep Pulse Therapy Device and Disposable Ablation Electrode Needles. The products have successfully obtained the Import Medical Device Distribution License issued by the Government of the Republic of Indonesia.

This accomplishment marks another significant innovation breakthrough for Nortion Medical, following its previous achievements of receiving the CE Marking approval for market access in the European Union and the U.S. FDA's Breakthrough Device Designation (BDD). It represents a solid step forward in the company's global market expansion strategy.

Product Advantages and Innovations

NORTION's Composite Steep Pulse Therapy Device leverages pulsed ablation electric field technology to deliver a precision, safe, and minimally invasive solution for the clinical treatment of prostate cancer and benign prostatic hyperplasia (BPH).

he system overcomes vascular, mucosal, and neurological damage associated with traditional therapies, significantly reducing surgical trauma and shortening postoperative recovery time. Crucially, it preserves patients' normal functional structures, thereby preventing complications such as urinary incontinence and sexual dysfunction.

his breakthrough substantially enhances patients' quality of life, offering a new therapeutic option for individuals with prostate cancer and BPH.

Strategic Significance

1、Geographic Expansion

Indonesia, as one of Southeast Asia's largest economies, boasts a substantial population base and significant healthcare demand. Securing this distribution license opens market access for NORTION Medical to Indonesia's healthcare sector.

The company will forge strategic collaborations with local healthcare institutions and partners to effectively address Indonesian patients' growing need for high-quality, innovative medical devices. This initiative will bring tangible benefits to patients while advancing clinical outcomes.

2、International Cooperation and Exchange

Securing this license also presents a new opportunity for international cooperation and exchange between NuoSheng Medical and Indonesia in the healthcare sector. NuoSheng Medical will seize this opportunity to engage in extensive collaboration with Indonesian medical institutions, research organizations, and enterprises. Together, we will collaborate on technical R&D, clinical trials, and academic exchanges. These efforts will continuously enhance NuoSheng Medical's technical capabilities and innovation capacity within the global healthcare field, promote the common development of all parties in the health sector, and contribute to the advancement of global medical endeavors.

Moving forward, NuoSheng Medical will continue to uphold its corporate philosophy of 'Professionalism, Pragmatism, Customer Success, and Commitment Delivery.' We will persistently increase R&D investment, enhance product quality and service standards, and actively expand our presence in both domestic and international markets.

Building on securing the import license for medical device distribution in Indonesia, we will further strengthen collaboration with medical institutions and partners worldwide. Together, we will advance the development of the medical device industry and remain dedicated to providing global patients with premium and efficient medical products and services.